The FDA approves the Allurion balloon for weight loss, which is swallowed and doesn't require a procedure for removal. Doctors explain how it works.

Allurion saw its shares jump roughly 60% on Monday, Feb. 23, as the FDA signed off on the medtech’s premarket approval ...

Outside the US, over 200,000 patients have received the Smart Capsule.

The device is administered as a swallowable capsule that is filled with liquid by a physician and naturally leaves the body after approximately 4 months.

Other intragastric balloon systems, including Orbera and ReShape, have been approved for weight loss but require removal with an outpatient procedure. They have also been linked to serious outcomes ...

Allurion Technologies has won FDA approval for what it said is an alternative to GLP-1s and bariatric surgery. The Natick, MA-based company received a PMA for the Allurion Gastric Balloon System, ...

Officially launched in 2015, FDA has approved the first-ever gastric balloon that helps reduce body weight by 14 per cent.

Allurion Technologies (NYSE:ALUR) announced today that the FDA granted premarket approval (PMA) for its Allurion Gastric Balloon System.

Shantanu Gaur, MD, founded Allurion in 2009 while he was a student at Boston-based Harvard Medical School. Now, as CEO of the Natick, Mass.-based company, he’s leading efforts to redefine obesity care ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the presentation of four ...

Findings from two abstracts presented at the American Society for Metabolic & Bariatric Surgery (ASMBS) 2025 Annual Meeting reinforce the role of the AI-powered Allurion Program in delivering ...